Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Rectum Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00006112
What this trial is testing

Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer

Who this might be right for
Carcinoma of the AppendixColorectal CancerPrimary Peritoneal Cavity Cancer
Gustave Roussy, Cancer Campus, Grand Paris
Not applicableStudy completedNCT00039611
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT00007826
What this trial is testing

Monoclonal Antibody Therapy and/or Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Onyvax
Not applicableEnded earlyNCT00003843
What this trial is testing

Irinotecan in Treating Patients With Colorectal Cancer

Who this might be right for
Colorectal Cancer
California Cancer Consortium 28
Testing effectiveness (Phase 2)UnknownNCT00072553
What this trial is testing

Celecoxib, Leucovorin, Fluorouracil, and Oxaliplatin in Treating Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group
Testing effectiveness (Phase 2)Ended earlyNCT01347645
What this trial is testing

Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Eisai Inc. 82
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00043004
What this trial is testing

Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
European Organisation for Research and Treatment of Cancer - EORTC 119
Testing effectiveness (Phase 2)UnknownNCT02510378
What this trial is testing

Short Course Radiotherapy Combined With Chemotherapy in Stage IV Rectal Cancer With Resectable Liver Metastases

Who this might be right for
Stage IV Rectal Cancer, Liver Metastasis, Resectable
Chinese Academy of Medical Sciences 47
Not applicableStudy completedNCT05462314
What this trial is testing

Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies

Who this might be right for
Gastrointestinal CancerPancreatic CancerEsophageal Cancer+4 more
Viome 24
Early research (Phase 1)Ended earlyNCT00088933
What this trial is testing

Vaccine Therapy and Sargramostim With or Without Docetaxel in Treating Patients With Metastatic Lung Cancer or Metastatic Colorectal Cancer

Who this might be right for
Extensive Stage Small Cell Lung CancerRecurrent Colon CancerRecurrent Non-small Cell Lung Cancer+5 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Ended earlyNCT01186705
What this trial is testing

Clinical And Translational Study Of MK-2206 In Patients With Metastatic KRAS-Wild-Type, PIK3CA-Mutated, Colorectal Cancer

Who this might be right for
Colon CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 1
Early research (Phase 1)Study completedNCT01434069
What this trial is testing

Phase I Trial of Combination of FOLFIRI and SOM 230

Who this might be right for
Gastrointestinal Tumor
H. Lee Moffitt Cancer Center and Research Institute 16
Early research (Phase 1)Study completedNCT00003427
What this trial is testing

Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer

Who this might be right for
Anal CancerColorectal CancerEsophageal Cancer+7 more
Memorial Sloan Kettering Cancer Center 36
Not applicableStudy completedNCT00897754
What this trial is testing

Gene Expression in Patients With Advanced or Metastatic Colorectal Cancer Receiving Bevacizumab

Who this might be right for
Colorectal Cancer
ECOG-ACRIN Cancer Research Group 200
Testing effectiveness (Phase 2)Study completedNCT00313794
What this trial is testing

Study of Ticilimumab in Patients With Metastatic Colorectal Cancer Whose Disease Had Progressed After Treatment

Who this might be right for
Colorectal Neoplasms
AstraZeneca 49
Testing effectiveness (Phase 2)Study completedNCT00007943
What this trial is testing

Gemcitabine in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Wake Forest University Health Sciences 15
Testing effectiveness (Phase 2)Study completedNCT00003254
What this trial is testing

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Who this might be right for
Colorectal Cancer
SWOG Cancer Research Network 75
Large-scale testing (Phase 3)Study completedNCT00003594
What this trial is testing

Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Alliance for Clinical Trials in Oncology 1,691
Next Page